LifeMD outlines $250M+ annualized revenue run rate target by Q4 2026 amid record GLP-1 demand and expanded partnerships [Seeking Alpha]
LifeMD, Inc. (LFMD)
Company Research
Source: Seeking Alpha
Justin Schreiber, Chairman & CEO, opened by stating LifeMD ended the year "with over 322,000 active subscribers, nearly $37 million in cash and no debt, giving us the strongest balance sheet and liquidity position in the company's history." The Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up Quick Insights Key drivers include subscriber growth, pharmacy expansion, new product launches (especially Wegovy), partnerships with pharmaceutical companies, and investments in AI and infrastructure. Demand has doubled with strong new-patient sign-ups, especially for the oral Wegovy product, leading to record acquisition volumes and lower customer acquisition costs. Short-term profit is pressured by high marketing and investment spend for GLP-1; long-term therapy retention is not yet clear, and details of future drug launches may be limited by regulatory or competitive risks.
Show less
Read more
Impact Snapshot
Event Time:
LFMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFMD alerts
High impacting LifeMD, Inc. news events
Weekly update
A roundup of the hottest topics
LFMD
News
- LifeMD appoints Atul Kavthekar as CFO [Seeking Alpha]Seeking Alpha
- LifeMD (LFMD) was upgraded by Mizuho from "neutral" to "outperform". They now have a $8.00 price target on the stock, up from $6.00.MarketBeat
- LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership TeamGlobeNewswire
- LifeMD (LFMD) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=LFMD&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "sell" to "hold".MarketBeat
- LifeMD (LFMD) was given a new $10.00 price target by Loop Capital.MarketBeat
LFMD
Earnings
- 3/9/26 - Beat
LFMD
Sec Filings
- 3/18/26 - Form 8-K
- 3/10/26 - Form 10-K
- 3/9/26 - Form 8-K
- LFMD's page on the SEC website